The aim of this study was to evaluate the impact of Transtheoretical Model-based Motivational Interviewing on self-efficacy and illness adjustment in hemodialysis patients.
Hemodialysis patients often face challenges in adhering to dietary, fluid, and medication guidelines due to the lengthy nature of the dialysis sessions and various associated restrictions.
This study was conducted between June 2022 and March 2023 at hemodialysis centers in eastern Turkey. It included 30 patients in the experimental group and 30 in the control group. The experimental group received six sessions of Transtheoretical Model-based motivational interviewing, while the control group received no intervention. This pretest-posttest randomized controlled trial was registered in the Clinical Trials Registry (NCT06706843).
The results indicated a significant improvement in GSES scores. A significant difference was found between the groups in pre-test scores (p < 0.05), and a statistically significant difference was also observed in Posttest scores (p < 0.05). Within-group comparisons revealed significant differences between pretest and posttest scores for the experimental group (p < 0.05). There was a significant difference between pre-test and Posttest scores in the control group (p < 0.05). In the SDBM-NOS showed a significant difference between the experimental and control groups in the dietary adherence subscale at Posttest (p < 0.05), but no significant difference was found in the other subscales. In the experimental group, a significant improvement was observed between pre-test and Posttest in terms of total ESRD-AS score, fluid compliance and dietary compliance (p < 0.05). In the control group, no significant difference was found for any variable (p > 0.05). A significant negative correlation was found between GSES and ESRD-AS.
In conclusion, Transtheoretical Model-based Motivational Interviewing was found to significantly improve treatment adherence and self-efficacy in chronic hemodialysis patients, contributing to better illness adjustment.
Trial Registration: ClinicalTrials.gov identifier: NCT06706843.